Revenue Recognition in the Age of Biotech Breakthroughs
20+ years of IFRS deal accounting across pharma, biotech, and MedTech — distilled into one practical guide for finance leaders who need to get it right before the deal is signed.
Flip through sample pages or read the full chapter breakdown — your choice.
Ensure accounting treatment is determined before the term sheet is signed, not after.
A working reference for every stage of the deal lifecycle — from structuring to post-close reporting.
Understand the accounting consequences of deal structures before they become constraints Finance must manage for years.
Independent reference for challenging accounting judgements on complex licensing arrangements.
An authoritative reference for IFRS 15 in the life sciences context — bridging the gap between the standard and real-world application.
All formats contain the complete text. Ebook delivers instantly. Print ships via Lulu's local European fulfilment network.
The book provides the principles. The frameworks put them to work on live deals. Buy together and save.
Save €65
Get Starter bundle →Save €131
Get CFO Complete bundle →Save €84
Get Deal Team bundle →Save €278 — the complete MIO Consult toolkit
Get the Full Library →Endorsement 1 — in progress
Endorsement 2 — in progress
Endorsement 3 — in progress
